Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2020 | 4 |
2021 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health.
Front Immunol. 2021 Jan 21;11:595297. doi: 10.3389/fimmu.2020.595297. eCollection 2020.
Front Immunol. 2021.
PMID: 33552052
Free PMC article.
Review.
Immunological mechanisms of inducing HIV immunity in infants.
Fouda GG, De Paris K, Levy O, Marchant A, Gray G, Permar S, Marovich M, Singh A.
Fouda GG, et al.
Vaccine. 2020 Jan 16;38(3):411-415. doi: 10.1016/j.vaccine.2019.11.011. Epub 2019 Nov 21.
Vaccine. 2020.
PMID: 31761501
Free PMC article.
Review.
Item in Clipboard
Four-parameter paired response curve for serial dilution assays.
Fong Y, Permar SR, Tomaras GD.
Fong Y, et al.
J Biopharm Stat. 2021 Sep 3;31(5):634-649. doi: 10.1080/10543406.2021.1931271. Epub 2021 Jun 7.
J Biopharm Stat. 2021.
PMID: 34097580
Free PMC article.
Item in Clipboard
Shortening HIV vaccine regimens to achieve high coverage.
Blasi M, Fouda GG.
Blasi M, et al.
Lancet HIV. 2020 Jun;7(6):e377-e378. doi: 10.1016/S2352-3018(20)30039-4. Epub 2020 Feb 17.
Lancet HIV. 2020.
PMID: 32078816
Free PMC article.
No abstract available.
Item in Clipboard
Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence.
Goswami R, Berendam SJ, Li SH, Nelson AN, De Paris K, Van Rompay KKA, Permar SR, Fouda GG.
Goswami R, et al.
PLoS Pathog. 2020 Nov 12;16(11):e1008983. doi: 10.1371/journal.ppat.1008983. eCollection 2020 Nov.
PLoS Pathog. 2020.
PMID: 33180867
Free PMC article.
No abstract available.
Item in Clipboard
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
McGuire EP, Fong Y, Toote C, Cunningham CK, McFarland EJ, Borkowsky W, Barnett S, Itell HL, Kumar A, Gray G, McElrath MJ, Tomaras GD, Permar SR, Fouda GG.
McGuire EP, et al.
J Virol. 2017 Dec 14;92(1):e01070-17. doi: 10.1128/JVI.01070-17. Print 2018 Jan 1.
J Virol. 2017.
PMID: 29021402
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite